SCHEMBL5157969

SCHEMBL5157969

O[C@@H]1CCN(Cc2ccccc2)C[C@@H]1O

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FUCA1 P04066 2/20 0.66
ALDH1A1 P00352 1/20 0.63
SLC18A3 Q16572 1/20 0.61
ACHE P22303 2/20 0.56
BCHE P06276 1/20 0.55
BACE1 P56817 1/20 0.55
GBA1 P04062 1/20 0.55
CCR3 P51677 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C19 P33261 1/20 0.54
SIGMAR1 Q99720 2/20 0.53
GRIN1 Q05586 1/20 0.53
GRIN2B Q13224 1/20 0.53
DRD2 P14416 1/20 0.51
DRD4 P21917 1/20 0.51
DRD3 P35462 1/20 0.51
CXCR4 P61073 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5157349 1.00 FUCA1 (0.66) FUCA1ALDH1A1SLC18A3ACHEBCHE
SCHEMBL84802 0.87 FUCA1 (0.85) FUCA1ALDH1A1SLC18A3ACHEGBA1
SCHEMBL562632 0.87 FUCA1 (0.85) FUCA1ALDH1A1SLC18A3ACHEGBA1
SCHEMBL20017877 0.87 FUCA1 (0.85) FUCA1ALDH1A1SLC18A3ACHEGBA1
SCHEMBL5155562 0.87 FUCA1 (0.85) FUCA1ALDH1A1SLC18A3ACHEGBA1
SCHEMBL71063 0.87 FUCA1 (0.85) FUCA1ALDH1A1SLC18A3ACHEGBA1
Hydrochloric Acid SCHEMBL10840201 0.85 FUCA1 (0.81) FUCA1ALDH1A1SLC18A3GBA1SIGMAR1
SCHEMBL765298 0.85 ACHE (0.60) FUCA1ALDH1A1SLC18A3ACHEBCHE
SCHEMBL3846308 0.85 ALDH1A1 (0.58) FUCA1ALDH1A1SLC18A3ACHEBCHE
SCHEMBL2178046 0.85 FUCA1 (0.60) FUCA1ALDH1A1SLC18A3ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740572-A1 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS CONTAINING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-01-10 EP disclosed
WO-2005103031-A1 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS CONTAINING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 WO disclosed
US-20050239826-A1 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239826-A1 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds MCHR1, MCHR2, GPR119 FUCA1 4312/4885ALDH1A1 1855/4885SLC18A3 1608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.